From amoeboid myosin to unique targeted medicines for a genetic cardiac disease.

ABSTRACT: The importance of fundamental basic research in the quest for much needed clinical treatments is a story that constantly must be retold. Funding of basic science in the USA by the National Institutes of Health and other agencies is provided under the assumption that fundamental research eventually will lead to improvements in healthcare worldwide. Understanding how basic research is connected to clinical developments is important, but just part of the story. Many basic science discoveries never see the light of day in a clinical setting because academic scientists are not interested in or do not have the inclination and/or support for entering the world of biotechnology. Even if the interest and inclination are there, often the unknowns about how to enter that world inhibit taking the init

SUBMITTER: Spudich JA 

PROVIDER: S-EPMC11550953 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature